EACT Position on ESMA Report on Use of OTC Derivatives by Non-Financial Counterparties

The EACT has published a position statement on the report by the European Securities and Markets Authority (ESMA) on the use of OTC derivatives by non-financial counterparties. We are very concerned by ESMA's recommendation to remove the hedging exemption currently part of the EMIR Regulation, as hedging plays an important economic role and removing the exemption would have severe consequences on companies in the real economy.